These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3411443)

  • 1. The effects of platinum levels in plasma, urine, and kidney on blood urea nitrogen levels after cisplatin injection in rats.
    Uozumi J; Litterst CL
    J Pharmacobiodyn; 1988 Apr; 11(4):277-83. PubMed ID: 3411443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of cisplatin on renal ATPase activity in vivo and in vitro.
    Uozumi J; Litterst CL
    Cancer Chemother Pharmacol; 1985; 15(2):93-6. PubMed ID: 2990752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of Pt in the urine and kidney of the cisplatin treated rat.
    Mason RW; Hogg SJ; Edwards IR
    Toxicology; 1986 Feb; 38(2):219-26. PubMed ID: 3945972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the diuretics mannitol or acetazolamide on nephrotoxicity and physiological disposition of cisplatin in rats.
    Osman NM; Copley MP; Litterst CL
    Cancer Chemother Pharmacol; 1984; 13(1):58-62. PubMed ID: 6428763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal accumulation and urinary excretion of cisplatin in diabetic rats.
    Valentovic MA; Scott LA; Madan E; Yokel RA
    Toxicology; 1991; 70(2):151-62. PubMed ID: 1763412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of disopyramide and verapamil on renal disposition and nephrotoxicity of cisplatin in rats.
    Hanada K; Odaka K; Kudo A; Ogata H
    Pharm Res; 1999 Oct; 16(10):1589-95. PubMed ID: 10554102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of methylprednisolone on platinum kinetics and urinary enzyme excretion following intravenous cisplatin in vivo and on the growth inhibition of LLC-PK1 cells by cisplatin in vitro.
    Uozumi J; Koikawa Y; Yasumasu T; Tokuda N; Ueda T; Kumazawa J
    Res Exp Med (Berl); 1996; 196(4):211-7. PubMed ID: 8903096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effect of acetylcysteine on cisplatin nephrotoxicity in rats.
    Appenroth D; Winnefeld K; Schröter H; Rost M
    J Appl Toxicol; 1993; 13(3):189-92. PubMed ID: 8326088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced renal accumulation and toxicity of cisplatin in experimental galactosemia.
    Cacini W; Harden EA; Skau KA
    Proc Soc Exp Biol Med; 1993 Jul; 203(3):348-53. PubMed ID: 8516346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of cisplatin and carboplatin on pharmacokinetics, nephrotoxicity and effect on renal nuclear DNA synthesis in rats.
    Yasumasu T; Ueda T; Uozumi J; Mihara Y; Kumazawa J
    Pharmacol Toxicol; 1992 Feb; 70(2):143-7. PubMed ID: 1508841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin nephrotoxicity: inhibition of gamma-glutamyl transpeptidase blocks the nephrotoxicity of cisplatin without reducing platinum concentrations in the kidney.
    Hanigan MH; Gallagher BC; Taylor PT
    Am J Obstet Gynecol; 1996 Aug; 175(2):270-3; discussion 273-4. PubMed ID: 8765241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of sodium thiosulfate on subcellular localization of platinum in rat kidney after treatment with cisplatin.
    Uozumi J; Litterst CL
    Cancer Lett; 1986 Sep; 32(3):279-83. PubMed ID: 3768854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between plasma and urinary platinum pharmacokinetics with cisplatin nephrotoxicity in breast cancer patients].
    Guo JH
    Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):150-3. PubMed ID: 1618086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a cisplatin-chondroitin sulfate A complex in reducing the nephrotoxicity of cisplatin.
    Zhang JS; Imai T; Otagiri M
    Arch Toxicol; 2000 Aug; 74(6):300-7. PubMed ID: 11005675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cis-diamminedichloroplatinum (II)--induced renal toxicity in the rat.
    Jones MM; Basinger MA; Mitchell WM; Bradley CA
    Cancer Chemother Pharmacol; 1986; 17(1):38-42. PubMed ID: 3698175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prophylactic effect of methylprednisolone on cisplatin-induced nephrotoxicity].
    Koikawa Y
    Fukuoka Igaku Zasshi; 1995 Feb; 86(2):31-9. PubMed ID: 7729781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and toxicodynamics of cisplatin and its metabolites in rats: relationship between renal handling and nephrotoxicity of cisplatin.
    Hanada K; Ninomiya K; Ogata H
    J Pharm Pharmacol; 2000 Nov; 52(11):1345-53. PubMed ID: 11186242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin pharmacokinetics and its nephrotoxicity in diabetic rabbits.
    Najjar TA; Saad SY
    Chemotherapy; 2001; 47(2):128-35. PubMed ID: 11173815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative nephrotoxicity of cisplatin, cis-[Pt(NH3)2(guanosine)2]2+, and the hydrolysis product of cisplatin in the rat.
    Jones MM; Basinger MA; Beaty JA; Holscher MA
    Cancer Chemother Pharmacol; 1991; 29(1):29-32. PubMed ID: 1742846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity in rats: importance of area under the concentration-time curve (AUC) as the major toxicodynamic determinant in vivo.
    Nagai N; Ogata H
    Cancer Chemother Pharmacol; 1997; 40(1):11-8. PubMed ID: 9137523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.